Call for Abstract

19th International Conference on Allergic Diseases and Clinical Immunology , will be organized around the theme “Advancing Allergic Diseases and Immunology: Integrating Science, Clinical Practice, and Innovation”

Allergic Conference 2024 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Allergic Conference 2024

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

This track focuses on understanding the underlying immunological mechanisms that drive allergic diseases such as asthma, allergic rhinitis, atopic dermatitis, and food allergies.

  • Cellular and molecular mechanisms of allergic sensitization
  • Allergen recognition and immune response
  • Immunological basis of allergic inflammation

This track explores innovative strategies and treatments for managing allergic conditions, including novel drugs, immunotherapies, and biologics.

  • Immunomodulatory therapies for allergy prevention and treatment
  • Biologic agents targeting allergic pathways
  • Personalized medicine approaches for allergic disease management

This track delves into the mechanisms underlying primary and secondary immunodeficiencies, including genetic defects, immune dysregulation, and infectious causes.

  • Primary immunodeficiencies: genetic and molecular basis
  • Secondary immunodeficiencies: acquired causes and mechanisms
  • Immunodeficiency-associated complications and management

This track explores strategies for modulating the immune system to prevent or treat allergic diseases, including immunotherapy, probiotics, and dietary interventions.

  • Immunotherapy approaches for allergic desensitization
  • Probiotics and microbiome modulation in allergy prevention
  • Dietary factors influencing immune regulation and allergic responses

This track highlights recent advancements in molecular immunology relevant to allergic diseases, including cytokine signaling, immune cell activation, and gene regulation.

  • Cytokine networks in allergic inflammation
  • Immune cell signaling pathways in allergy and asthma
  • Epigenetic regulation of allergic immune responses

This track focuses on the identification, characterization, and standardization of allergens from various sources, including foods, pollen, dust mites, and insects.

  • Allergen structure and function
  • Allergenicity assessment and measurement techniques
  • Allergen component-resolved diagnostics

This track examines the efficacy, safety, and mechanisms of allergen-specific immunotherapy (AIT) and other immunomodulatory therapies for allergic disorders.

  • Subcutaneous and sublingual immunotherapy
  • Novel approaches in allergen-specific immunotherapy
  • Immunomodulatory mechanisms of AIT

This track explores the genetic basis of allergic diseases, including genome-wide association studies (GWAS), genetic polymorphisms, and gene-environment interactions.

  • Genetic risk factors for allergic disorders
  • Immunogenetic determinants of asthma, atopic dermatitis, and allergic rhinitis
  • Gene-environment interactions in allergic susceptibility

This track investigates the complex interactions between the microbiota and the immune system in the development and modulation of allergic diseases.

  • Gut microbiota composition and allergic sensitization
  • Microbiota-host immune interactions in allergy and asthma
  • Therapeutic targeting of the microbiota in allergic disorders

This track explores the immunological mechanisms underlying autoimmune diseases and their relationship with allergic disorders, including autoantibody production, T-cell dysregulation, and immune tolerance.

  • Immunopathogenesis of autoimmune diseases
  • Shared mechanisms between autoimmunity and allergy
  • Immunomodulatory therapies for autoimmune-related allergic manifestations

This track focuses on the identification and validation of biomarkers for the diagnosis, prognosis, and monitoring of allergic diseases, as well as their utility in guiding therapeutic decisions.

  • Serum and cellular biomarkers in allergic diseases
  • Biomarker panels for allergic phenotyping and endotyping
  • Biomarker-driven approaches to personalized allergy management

This track examines the immunological mechanisms underlying food allergy, including oral tolerance, food sensitization, and immune responses to dietary antigens.

  • Gut immunology and food allergy development
  • Immunopathogenesis of IgE-mediated and non-IgE-mediated food allergies
  • Diagnostic and therapeutic approaches to food allergy management


This track explores the immunological mechanisms underlying vaccine responses and the impact of vaccines on allergic diseases, including vaccine adjuvants, immune memory, and vaccine safety.

  • Immunogenicity and efficacy of vaccines in allergic individuals
  • Vaccine-induced immune modulation and allergic outcomes
  • Vaccination strategies for allergic populations

This track investigates the inflammatory pathways involved in asthma and allergic rhinitis, including type 2 inflammation, airway remodeling, and the role of epithelial cells.

  • Type 2 cytokines and effector cells in asthma and allergic rhinitis
  • Airway epithelial barrier dysfunction in allergic airway diseases
  • Targeting inflammatory pathways for asthma and allergic rhinitis therapy

This track focuses on the immunological mechanisms underlying drug allergies, including immediate hypersensitivity reactions, delayed-type hypersensitivity, and drug-specific immune responses.

  • Drug allergens and haptenation mechanisms
  • Immunological testing for drug allergy diagnosis
  • Management and desensitization strategies for drug allergic patients

This track presents real-world case studies highlighting challenging diagnostic dilemmas, treatment decisions, and management strategies for various allergic disorders.

  • Pediatric allergy case studies
  • Adult allergy case studies
  • Multidisciplinary approaches to complex allergy cases

This track showcases ongoing and completed clinical trials investigating novel therapies, diagnostic approaches, and preventive strategies for allergic diseases and immunodeficiencies.

  • Phase I-IV clinical trials in allergy and immunology
  • Translational research bridging bench to bedside in allergic disorders
  • Regulatory considerations and challenges in allergy clinical research

This track focuses on epidemiological studies investigating the prevalence, incidence, risk factors, and trends of allergic diseases and immunodeficiencies at the population level.

  • Global burden of allergic diseases
  • Environmental factors influencing allergic disease epidemiology
  • Socioeconomic disparities in allergic disease prevalence and outcomes

This track examines the integration of digital health technologies, telemedicine platforms, mobile applications, and wearable devices in allergy diagnosis, management, and patient education.

  • Teleconsultation and remote monitoring for allergic patients
  • Mobile health apps for allergy symptom tracking and management
  • Artificial intelligence and machine learning in allergy diagnosis and risk prediction